Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse

Blood

Volumn 88, Issue 7, 1996, Pages 2738-2744

  De Franceschi, Lucia ^b   Beuzard, Yves ^b   Jouault, Helene ^b   Brugnara, Carlo ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MAGNESIUM; POTASSIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE TRANSPORT; CHLORIDE TRANSPORT; CONTROLLED STUDY; DIET; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; HEMATOCRIT; HEMOGLOBIN DETERMINATION; MEAN CORPUSCULAR HEMOGLOBIN; MOUSE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SICKLE CELL; TRANSGENIC MOUSE;

EID: 0029793542     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2738.bloodjournal8872738     Document Type: Article

References (41)

1. Eaton WA, Hofrichter J: Hemoglobin S gelation and sickle cell disease. Blood 70:1245, 1987
2. Brittenham GM, Schechter AN, Noguchi CT: Hemoglobin S polymerization: Primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood 65:183, 1985
3. Brugnara C, Bunn HF, Tosteson DC: Regulation of erythrocyte cation and water content in sickle cell anemia. Science 2232:388, 1986
4. Canessa M, Spalvins A, Nagel RL: Volume dependent and NEM-stimulated K/Cl cotransport is elevated in SS, SC and CC human red cells. FEBS Lett 200:197, 1986
5. Glader BE, Nathan NG: Cation permeability alteration during sickling: Relationship to cation composition and cellular dehydration of irreversibly sickle cell. Blood 51:983, 1978
6. Bookchin RM, Ortiz OE, Lew VL: Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J Clin Invest 87:113, 1991
7. Gardos G: The function of calcium in the potassium permeability of human erythrocytes. Biochem Biophys Acta 30:653, 1958
8. + transport and cell dehydration in sickle cell erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 92:520, 1993
9. + transport and reverses erythrocyte dehydration in transgenic SAD mice: A model for therapy of sickle cell disease. J Clin Invest 93:1670, 1994
10. Brugnara C, Gee B, Armsby C, Kurth S, Sakamoto M, Rifai N, Alper SL, Platt O: Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 97:1227, 1996
11. Brugnara C, Kopin AK, Bunn HF, Tosteson DC: Regulation of cation content and cell volume erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 75:1608, 1985
12. Brugnara C, Van Ha T, Tosteson DC: Acid pH induces formation of dense cells in sickle erythrocytes. Blood 74:487, 1989
13. Brugnara C, Tosteson DC: Inhibition of K transport by divalent cations in sickle erythrocytes. Blood 70:1810, 1987
14. Rayssignier Y, Gueux E, Motta R: Magnesium deficiency effects on fluidity and function of plasma and subcellular membranes, in Lasserre B & Durlach J (eds): Magnesium, a Relevant Ion. London, UK, Libbey, 1991, p 311
15. Ortiz OE, Lew VL, Bookchin RM: Deoxygenation permeabilizes sickle cell anemia red cells to magnesium and reverses its gradient in the dense cells. J Physiol (Lond) 427:211, 1990
16. Olukoga AO, Adewaye HO, Erasmus RT, Adedayn MA: Erythrocyte and plasma magnesium in sickle cell anemia. East Afr Med J 67:348, 1990
17. Bookchin R, Tifert JT, Davies SC, Vichinsky E, Lew VL: Magnesium therapy for sickle cell anemia: A new rationale. Proceedings of "New trends in therapy for Hemoglobinopathies and Thalassemias". INSERM, Paris, France, 1994, IX-6
18. Trudel M, Saadane N, Garel MC, Bardakdjan-Michau J, Blouquit Y, Guerquin-Kern JL, Royer-Fessard P, Vidaud D, Pachnis A, Romeo PH, Beuzard Y, Costantini F: Toward a transgenic mouse model of sickle cell disease hemoglobin SAD: EMBO J 11:3157, 1991
19. Trudel M, De Paepe ME, Chretien N, Saadane N, Jacmain J, Sorette M, Hoang T, Beuzard Y: The sickle cell disease of transgenic SAD mice. Blood 84:3189, 1994
20. De Paepe ME, Trudel M: The transgenic SAD mouse: A model of human sickle cell glomerulopathy. Kidney Int 46:1337, 1994
21. Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis S, Tattersfield A, Weiss S: Dietary magnesium, lung function, wheezing, and airway hyperreactivity in random adult population sample. Lancet 344:357, 1994
22. Chinn-Yee I, Keeney M, Lohmann RC: Flow cytometric reticulocyte analysis using thiazole orange; clinical experience and technical limitations. Clin Lab Haematol 13:177, 1991
23. Dannon D, Marikovsky Y. Determination of density distribution of red cell population. J Lab Clin Med 64:668, 1964
24. - cotransport in regulatory volume decrease. Am J Physiol 268:C894, 1995
25. De Franceschi L, Beuzard Y, Brugnara C: Sulphydryl oxidation and activation of red cell K-Cl cotransport in the transgenic SAD mouse. Am J Physiol 260:C899, 1995
26. Godfay K: Comparing the means of several groups. New Engl J Med 313:1450, 1985
27. Mazzanti L, Palla G, Cester N, Tranquilli AL, Valeniseff, Romani C: Effect of magnesium-deficient diet on cation transport in pregnant rabbits. Magnes Res 4:45, 1991
28. Elin RJ: Erythrocyte survival in magnesium-deficient rats. Proc Soc Exp Biol Med 142:1159, 1973
29. Heaton FW, Tongyai S, Motta C, Rayssiguier Y, Gueux E: Changes in the erythrocyte membrane during magnesium deficiency. Nutr Res 7:655, 1987
30. Rosa RM, Bierer BE, Thomas R, Stoff JS, Kruskall M, Robinson S, Bunn HF, Epstein FH: A study of induced hyponatremia in the prevention and treatment of sickle cell crisis. N Engl J Med 303:1138, 1980
31. Brugnara C, Tosteson DC: Cell volume, K transport and cell density in human erythrocytes. Am J Physiol 252:C269, 1987
32. ++ modulation. Blood 70:1861, 1987
33. Henrotte JG, Pla M, Dausset J: HLA- and H-2-associated variations of intra- and extracellular magnesium content. Proc Natl Acad Sci USA 87:1894, 1990
34. Ofosu MD, Castro O, Alarif L: Sickle cell leg ulcers are associated with HLA-B35 and Cw4. Arch Dermatol 123:482, 1987
35. Paolisso G, Scheen A, Cozzolino D, Di MG, Varricchio M, D'Onofrio F, Lefebvre PJ: Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 78:1510, 1994
36. Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, D'Onofrio F: Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 55:1161, 1992
37. Zemel PC, Zemel MB, Urberg M, Douglas FL, Geiser R, Sowers JR: Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr 51:665, 1990
38. Anstall HB, Huntsman RG, Lehmann H, Hayward GH, Weitzman D: The effect of magnesium on blood coagulation in human subjects. Lancet 1:814, 1959
39. Lehmann H: Treatment of sickle cell anemia. Br Med J 1:1158, 1963
40. Basu AK, Woodruff AW: Effect of acetazolamide and magnesium therapy on erythrocyte survival in sickle-cell anemia and sickle-cell-haemoglobin-C disease. Trans R Soc Trop Med Hyg 60:64, 1966
41. Franco RS, Polascak M, Thompson H, Joiner C: K/Cl cotransport activity in light versus dense transferrine receptor-positive sickle reticulocytes. J Clin Invest 95:2573, 1995